Feng Y - Search Results

1

Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.

Feng Y, Pollock BG, Ferrell RE, Kimak MA, Reynolds CF 3rd, Bies RR. Feng Y, et al. Br J Clin Pharmacol. 2006 May;61(5):558-69. doi: 10.1111/j.1365-2125.2006.02629.x. Br J Clin Pharmacol. 2006. PMID: 16669849 Free PMC article. Clinical Trial.

2

Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects.

Bies RR, Feng Y, Lotrich FE, Kirshner MA, Roose S, Kupfer DJ, Pollock BG. Bies RR, et al. Among authors: feng y. J Clin Pharmacol. 2004 Dec;44(12):1352-9. doi: 10.1177/0091270004269647. J Clin Pharmacol. 2004. PMID: 15545305 Clinical Trial.

3

Administration of enoxaparin by continuous infusion in a naturalistic setting: analysis of renal function and safety.

Kane-Gill SL, Feng Y, Bobek MB, Bies RR, Pruchnicki MC, Dasta JF. Kane-Gill SL, et al. Among authors: feng y. J Clin Pharm Ther. 2005 Jun;30(3):207-13. doi: 10.1111/j.1365-2710.2005.00634.x. J Clin Pharm Ther. 2005. PMID: 15896237

4

Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.

Feng Y, Green B, Duffull SB, Kane-Gill SL, Bobek MB, Bies RR. Feng Y, et al. Br J Clin Pharmacol. 2006 Aug;62(2):165-76. doi: 10.1111/j.1365-2125.2006.02650.x. Br J Clin Pharmacol. 2006. PMID: 16842391 Free PMC article.

5

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study.

Feng Y, Pollock BG, Coley K, Marder S, Miller D, Kirshner M, Aravagiri M, Schneider L, Bies RR. Feng Y, et al. Br J Clin Pharmacol. 2008 Nov;66(5):629-39. doi: 10.1111/j.1365-2125.2008.03276.x. Epub 2008 Jul 31. Br J Clin Pharmacol. 2008. PMID: 18771484 Free PMC article.

6

The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram.

Jin Y, Pollock BG, Frank E, Florian J, Kirshner M, Fagiolini A, Kupfer DJ, Gastonguay MR, Kepple G, Feng Y, Bies RR. Jin Y, et al. Among authors: feng y. J Clin Pharmacol. 2009 Feb;49(2):176-84. doi: 10.1177/0091270008327538. J Clin Pharmacol. 2009. PMID: 19179296 Free PMC article.

7

Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy.

Feng Y, Gastonguay MR, Pollock BG, Frank E, Kepple GH, Bies RR. Feng Y, et al. Neuropsychiatr Dis Treat. 2011;7:117-25. doi: 10.2147/NDT.S15921. Epub 2011 Mar 17. Neuropsychiatr Dis Treat. 2011. PMID: 21552314 Free PMC article.

8

Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma.

Feng Y, Masson E, Dai D, Parker SM, Berman D, Roy A. Feng Y, et al. Br J Clin Pharmacol. 2014 Jul;78(1):106-17. doi: 10.1111/bcp.12323. Br J Clin Pharmacol. 2014. PMID: 24433434 Free PMC article. Clinical Trial.

9

Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment.

Yang H, Feng Y, Xu XS. Yang H, et al. Among authors: feng y. Expert Opin Drug Metab Toxicol. 2014 Feb;10(2):229-48. doi: 10.1517/17425255.2014.864636. Expert Opin Drug Metab Toxicol. 2014. PMID: 24428494 Review.

10

Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in Patients With Metastatic Solid Tumors.

Agrawal S, Statkevich P, Bajaj G, Feng Y, Saeger S, Desai DD, Park JS, Waxman IM, Roy A, Gupta M. Agrawal S, et al. Among authors: feng y. J Clin Pharmacol. 2017 Mar;57(3):394-400. doi: 10.1002/jcph.818. Epub 2016 Sep 27. J Clin Pharmacol. 2017. PMID: 27557786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,714 results

Search Page

Filters